Good morning :)
Place Order
Add to Watchlist

Granules India Ltd

GRANULES Share Price

496.651.52% (+7.45)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

GRANULES Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

GRANULES Performance & Key Metrics

GRANULES Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
24.063.740.30%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.496.520.85%

GRANULES Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 8 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

GRANULES Company Profile

Granules India Limited is a pharmaceutical company that manufactures finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs).

Investor Presentation

View older View older 

May 28, 2025

PDF
View Older Presentations

GRANULES Similar Stocks (Peers)

Compare with peers Compare with peers 

GRANULES Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.50
36.50
1Y Return
11.19%
11.19%
Buy Reco %
87.88
87.88
PE Ratio
22.97
22.97
1Y Return
0.13%
0.13%
Buy Reco %
74.19
74.19
PE Ratio
19.39
19.39
1Y Return
10.43%
10.43%
Buy Reco %
56.67
56.67
PE Ratio
56.06
56.06
1Y Return
11.99%
11.99%
Buy Reco %
72.00
72.00
PE Ratio
21.17
21.17
1Y Return
10.72%
10.72%
Buy Reco %
46.43
46.43
Compare with Peers

GRANULES Forecast

GRANULES Forecasts

Price

Revenue

Earnings

GRANULES

GRANULES

Income

Balance Sheet

Cash Flow

GRANULES Income Statement

GRANULES Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 13.88%, vs industry avg of 9.02%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.07% to 1.18%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 11.38%, vs industry avg of 15.29%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue1,445.211,711.452,354.632,688.443,264.423,782.534,525.704,510.774,525.284,525.27
Raw Materialssubtract679.96902.901,338.971,314.921,590.282,036.422,352.652,208.223,536.373,536.38
Power & Fuel Costsubtract38.6748.2257.6859.7468.8574.6695.69100.64
Employee Costsubtract140.19165.21209.82259.04324.29366.44420.35550.24
Selling & Administrative Expensessubtract174.70216.04262.58313.30427.22521.25580.83696.63
Operating & Other expensessubtract78.2173.8326.11126.33-28.3243.92148.5794.66
Depreciation/Amortizationsubtract71.5176.20105.48136.95151.46158.63184.49207.33225.50225.50
Interest & Other Itemssubtract32.2633.0628.4627.0226.2823.2155.93105.82103.24103.24
Taxes & Other Itemssubtract65.2063.4089.11115.73154.90145.25170.58141.92158.65158.65
EPS7.395.509.3113.1921.8916.6521.0816.7320.6920.69
DPS0.901.001.001.001.501.501.501.501.501.50
Payout ratio0.120.180.110.080.070.090.070.090.070.07

GRANULES Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual Report Pending

Investor Presentation

May 28PDF
Jan 24PDF
Nov 6PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 9PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 16PDF
Jan 24PDF
Oct 20PDF
Aug 9PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

May 18PDF
Feb 8PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

GRANULES Stock Peers

GRANULES Past Performance & Peer Comparison

GRANULES Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Granules India Ltd24.063.740.30%
Sun Pharmaceutical Industries Ltd36.505.940.96%
Cipla Ltd22.974.521.07%
Dr Reddy's Laboratories Ltd19.393.880.61%

GRANULES Stock Price Comparison

Compare GRANULES with any stock or ETF
Compare GRANULES with any stock or ETF
GRANULES
Loading...

GRANULES Holdings

GRANULES Shareholdings

GRANULES Promoter Holdings Trend

GRANULES Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GRANULES Institutional Holdings Trend

GRANULES Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GRANULES Shareholding Pattern

GRANULES Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding38.84%11.57%10.88%15.15%23.57%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

GRANULES Shareholding History

GRANULES Shareholding History

Dec '23MarJunSepDec '24Mar18.78%19.57%20.39%19.49%15.87%15.15%

Mutual Funds Invested in GRANULES

Mutual Funds Invested in GRANULES

No mutual funds holding trends are available

Top 5 Mutual Funds holding Granules India Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
1.1718%2.29%0.08%45/88 (0)
1.0993%1.04%0.06%47/156 (0)
0.7605%1.18%-0.08%19/138 (-1)

Compare 3-month MF holding change on Screener

GRANULES Insider Trades & Bulk Stock Deals

GRANULES Insider Trades & Bulk Stock Deals

Loading...

smallcases containing GRANULES stock

smallcases containing GRANULES stock

Looks like this stock is not in any smallcase yet.

GRANULES Events

GRANULES Events

GRANULES Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GRANULES has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.30%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.01 every year

Dividends

Corp. Actions

Announcements

Legal Orders

GRANULES Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GRANULES has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.30%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.01 every year

GRANULES Upcoming Dividends

GRANULES Upcoming Dividends

Cash Dividend

Ex DateEx DateJul 31, 2025

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Jul 31, 2025

GRANULES Past Dividends

GRANULES Past Dividends

Cash Dividend

Ex DateEx DateJul 30, 2024

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Jul 30, 2024

Cash Dividend

Ex DateEx DateAug 3, 2023

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Aug 3, 2023

Cash Dividend

Ex DateEx DateJul 19, 2022

Final
Final | Div/Share: ₹0.75

Dividend/Share

0.75

Ex DateEx Date

Jul 19, 2022

Cash Dividend

Ex DateEx DateFeb 17, 2022

Interim 3
Interim 3 | Div/Share: ₹0.25

Dividend/Share

0.25

Ex DateEx Date

Feb 17, 2022

Cash Dividend

Ex DateEx DateNov 24, 2021

Interim 2
Interim 2 | Div/Share: ₹0.25

Dividend/Share

0.25

Ex DateEx Date

Nov 24, 2021

GRANULES Stock News & Opinions

GRANULES Stock News & Opinions

Spotlight
Granules India receives one observation from USFDA following inspection at Telangana facility

In a regulatory filing, the company stated that the USFDA conducted the inspection from 16 June to 20 June 2025. At the conclusion of the inspection, the USFDA issued a Form 483 with one observation. The company stated that it will respond to this observation within the stipulated time frame. The Bonthapally facility is one of the world's largest single-site paracetamol API manufacturing plants by volume. Along with paracetamol APIs, the company has also established metformin and guaifenesin API manufacturing units at the same site. The official announcement was made on 20 June 2025, after market hours. Granules India is primarily involved in the manufacturing and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). The company's consolidated net profit rose by 17.3% to Rs 152.03 crore, on a 2.4% increase in total revenue from operations to Rs 1,196.82 crore in Q4 FY25, compared to Q4 FY24. The counter rose 0.31% to Rs 488.35 on the BSE. Powered by Capital Market - Live

2 days agoCapital Market - Live
Corporate
Granules India allots Equity shares

Granules India has approved the allotment of 1,00,000 equity shares in consequence of the exercise of stock options under ESOS 2009.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Granules India announces cessation of Vice President & Head- IT

Granules India announced that Krishnamohan B., shall to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Vice President & Head- IT with effect from the closure of business hours of 02 June 2025. Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Granules India consolidated net profit rises 17.26% in the March 2025 quarter

Net profit of Granules India rose 17.26% to Rs 152.03 crore in the quarter ended March 2025 as against Rs 129.65 crore during the previous quarter ended March 2024. Sales rose 2.37% to Rs 1196.82 crore in the quarter ended March 2025 as against Rs 1169.06 crore during the previous quarter ended March 2024. For the full year,net profit rose 23.74% to Rs 501.52 crore in the year ended March 2025 as against Rs 405.31 crore during the previous year ended March 2024. Sales declined 0.76% to Rs 4455.97 crore in the year ended March 2025 as against Rs 4490.16 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1196.821169.06 2 4455.974490.16 -1 OPM %21.0921.87 -21.2119.06 - PBDT230.30228.82 1 854.92754.56 13 PBT166.80175.64 -5 629.42547.23 15 NP152.03129.65 17 501.52405.31 24 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Board of Granules India recommends final dividend

Granules India announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 150%) , subject to the approval of the shareholders.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Granules India to convene AGM

Granules India announced that the 34th Annual General Meeting(AGM) of the company will be held on 7 August 2025.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Granules India standalone net profit declines 3.26% in the March 2025 quarter

Net profit of Granules India declined 3.26% to Rs 94.05 crore in the quarter ended March 2025 as against Rs 97.22 crore during the previous quarter ended March 2024. Sales declined 21.75% to Rs 730.46 crore in the quarter ended March 2025 as against Rs 933.47 crore during the previous quarter ended March 2024. For the full year,net profit declined 26.74% to Rs 319.34 crore in the year ended March 2025 as against Rs 435.92 crore during the previous year ended March 2024. Sales declined 20.66% to Rs 2967.57 crore in the year ended March 2025 as against Rs 3740.13 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales730.46933.47 -22 2967.573740.13 -21 OPM %16.0020.28 -19.0321.43 - PBDT133.91172.93 -23 542.71735.15 -26 PBT95.94136.52 -30 396.48591.30 -33 NP94.0597.22 -3 319.34435.92 -27 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Granules India to declare Quarterly Result

Granules India will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Granules India completes acquisition of Swiss-based CDMO - Senn Chemicals AG

Granules India announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. This marks a strategic milestone in Granules' transformation into a science- and innovation-led organization and extends its capabilities into the fast growing peptide therapeutics segment. The acquisition follows the signing of a definitive share purchase agreement in February 2025, under which Granules, through its wholly owned Indian subsidiary, Granules Peptides, acquired 100% of the equity of Senn Chemicals from the founding Senn family. Founded over 60 years ago, Senn Chemicals has built a strong reputation as a specialist in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), serving innovators and brand owners across pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets. Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Granules India allots 50,000 equity shares under ESOS

Granules India has allotted 50,000 equity shares under ESOS on 20 March 2025. Powered by Capital Market - Live

3 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Granules India Ltd (GRANULES) today?

    The share price of GRANULES as on 25th June 2025 is ₹496.65. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Granules India Ltd (GRANULES) share?

    The past returns of Granules India Ltd (GRANULES) share are
    • Past 1 week: -3.70%
    • Past 1 month: -4.19%
    • Past 3 months: -4.35%
    • Past 6 months: -18.04%
    • Past 1 year: 0.33%
    • Past 3 years: 90.54%
    • Past 5 years: 136.79%

  3. What are the peers or stocks similar to Granules India Ltd (GRANULES)?
  4. What is the dividend yield % of Granules India Ltd (GRANULES) share?

    The current dividend yield of Granules India Ltd (GRANULES) is 0.30.

  5. What is the market cap of Granules India Ltd (GRANULES) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Granules India Ltd (GRANULES) is ₹12065.46 Cr as of 25th June 2025.

  6. What is the 52 week high and low of Granules India Ltd (GRANULES) share?

    The 52-week high of Granules India Ltd (GRANULES) is ₹721 and the 52-week low is ₹422.

  7. What is the PE and PB ratio of Granules India Ltd (GRANULES) stock?

    The P/E (price-to-earnings) ratio of Granules India Ltd (GRANULES) is 24.06. The P/B (price-to-book) ratio is 3.74.

  8. Which sector does Granules India Ltd (GRANULES) belong to?

    Granules India Ltd (GRANULES) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Granules India Ltd (GRANULES) shares?

    You can directly buy Granules India Ltd (GRANULES) shares on Tickertape. Simply sign up, connect your demat account and place your order.